LAPIX Therapeutics
PrivateLast Round
Series A
Aug 5, 2024
Total Funding Raised
$11.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
LAPIX Therapeutics is a biopharmaceutical company that develops novel, orally bioavailable immune system restoration therapies for the treatment of autoimmune diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LAPIX Therapeutics Comparables
Compare LAPIX Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anokion | 78% | |
| Treg Therapeutics | 78% | |
| Merck & Co., Inc. | 72% |
LAPIX Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 5, 2024 | ||||
| Series A | Apr 27, 2023 | ||||
| Seed | Oct 18, 2022 | ||||
| Seed | Aug 23, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 1056% MoM, from 178 to 2.1K.
- Oct 18, 2022
$3.2M raised in Seed round.
LAPIX Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LAPIX Therapeutics's valuation, stock price, and market status.
Is LAPIX Therapeutics a public or private company?
LAPIX Therapeutics is a private company.
What is the current stock price of LAPIX Therapeutics?
LAPIX Therapeutics is a private company, so its shares have no public market price. Caplight tracks LAPIX Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LAPIX Therapeutics worth (valuation)?
Valuation information for LAPIX Therapeutics is not publicly available.
Can I buy LAPIX Therapeutics stock?
LAPIX Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LAPIX Therapeutics's last funding round?
LAPIX Therapeutics's most recent funding round was Series A on August 5, 2024.
Who are the main investors in LAPIX Therapeutics?
Investor information for LAPIX Therapeutics is not publicly disclosed.
Will LAPIX Therapeutics IPO soon?
No public IPO plans have been announced for LAPIX Therapeutics.
How can I track LAPIX Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in LAPIX Therapeutics's shares on secondary markets.